InSilico Medicine Cayman revenue jumps 287% to $106.3M
InSilico Medicine Cayman reported revenue up 287% YoY to $106.3M, net profit of $35.5M, and gross margin of 90.3%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.